Pangea Bio
2 known investors
Pangea Bio is a clinical-stage biotech company developing therapies that activate the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. Its lead candidate OT-003 and follow-on OT-1xx series target central nervous system disorders such as neurological and neuropsychiatric diseases.
BiotechDeep Tech
Investors · 2
Frequently asked questions
- What does Pangea Bio do?
- Pangea Bio is a clinical-stage biotech company developing therapies that activate the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. Its lead candidate OT-003 and follow-on OT-1xx series target central nervous system disorders such as neurological and neuropsychiatric diseases.
- Who are Pangea Bio's investors?
- Pangea Bio's investors include Metaplanet, Vox Capital.